Donald C. Goff
Department of Psychiatry
MGH Schizophrenia Program
Freedom Trail Clinic
Massachusetts General Hospital
USA
Name/email consistency: high
- A placebo-controlled study of sildenafil effects on cognition in schizophrenia. Goff, D.C., Cather, C., Freudenreich, O., Henderson, D.C., Evins, A.E., Culhane, M.A., Walsh, J.P. Psychopharmacology (Berl.) (2009)
- A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Goff, D.C., Lamberti, J.S., Leon, A.C., Green, M.F., Miller, A.L., Patel, J., Manschreck, T., Freudenreich, O., Johnson, S.A. Neuropsychopharmacology (2008)
- Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study. Goff, D.C., Cather, C., Gottlieb, J.D., Evins, A.E., Walsh, J., Raeke, L., Otto, M.W., Schoenfeld, D., Green, M.F. Schizophr. Res. (2008)
- Integrating general health care in private community psychiatry practice. Goff, D.C. J. Clin. Psychiatry (2007)
- Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. Goff, D.C., Keefe, R., Citrome, L., Davy, K., Krystal, J.H., Large, C., Thompson, T.R., Volavka, J., Webster, E.L. J. Clin. Psychopharmacol (2007)
- A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients. Goff, D.C., Herz, L., Posever, T., Shih, V., Tsai, G., Henderson, D.C., Freudenreich, O., Evins, A.E., Yovel, I., Zhang, H., Schoenfeld, D. Psychopharmacology (Berl.) (2005)
- Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. Goff, D.C., Cather, C., Evins, A.E., Henderson, D.C., Freudenreich, O., Copeland, P.M., Bierer, M., Duckworth, K., Sacks, F.M. J. Clin. Psychiatry (2005)
- A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Goff, D.C., Sullivan, L.M., McEvoy, J.P., Meyer, J.M., Nasrallah, H.A., Daumit, G.L., Lamberti, S., D'Agostino, R.B., Stroup, T.S., Davis, S., Lieberman, J.A. Schizophr. Res. (2005)
- Pharmacologic implications of neurobiological models of schizophrenia. Goff, D.C. Harv. Rev. Psychiatry (2005)
- Focus on polypharmacy in schizophrenia: does anyone truly benefit?. Goff, D.C., Freudenreich, O. Int. J. Neuropsychopharmacol. (2004)
- Folate, homocysteine, and negative symptoms in schizophrenia. Goff, D.C., Bottiglieri, T., Arning, E., Shih, V., Freudenreich, O., Evins, A.E., Henderson, D.C., Baer, L., Coyle, J. Am. J. Psychiatry (2004)
- A 23-year-old man with schizophrenia. Goff, D.C. JAMA (2002)
- Schizophrenia. Goff, D.C., Heckers, S., Freudenreich, O. Med. Clin. North Am. (2001)
- A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Goff, D.C., Tsai, G., Levitt, J., Amico, E., Manoach, D., Schoenfeld, D.A., Hayden, D.L., McCarley, R., Coyle, J.T. Arch. Gen. Psychiatry (1999)
- Glutamate in schizophrenia: clinical and research implications. Goff, D.C., Wine, L. Schizophr. Res. (1997)
- D-cycloserine added to clozapine for patients with schizophrenia. Goff, D.C., Tsai, G., Manoach, D.S., Flood, J., Darby, D.G., Coyle, J.T. Am. J. Psychiatry (1996)